<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A8D6A87B-48C3-49DC-8D55-AA7203607683"><gtr:id>A8D6A87B-48C3-49DC-8D55-AA7203607683</gtr:id><gtr:name>University of British Columbia (UBC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/872D8701-44D2-4D3C-B113-A795FA40D61F"><gtr:id>872D8701-44D2-4D3C-B113-A795FA40D61F</gtr:id><gtr:name>University of Helsinki</gtr:name><gtr:address><gtr:line1>Siltavuorenpenger 20 C</gtr:line1><gtr:line4>Helsinki</gtr:line4><gtr:line5>FI-00170</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/90586AE8-B1B4-4D85-B7CC-B9130F248E5C"><gtr:id>90586AE8-B1B4-4D85-B7CC-B9130F248E5C</gtr:id><gtr:name>University of Nebraska-Lincoln</gtr:name><gtr:address><gtr:line1>University of Nebraska-Lincoln</gtr:line1><gtr:line4>Lincoln</gtr:line4><gtr:line5>Nebraska</gtr:line5><gtr:postCode>68588-0340</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Anatomy</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A8D6A87B-48C3-49DC-8D55-AA7203607683"><gtr:id>A8D6A87B-48C3-49DC-8D55-AA7203607683</gtr:id><gtr:name>University of British Columbia (UBC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/872D8701-44D2-4D3C-B113-A795FA40D61F"><gtr:id>872D8701-44D2-4D3C-B113-A795FA40D61F</gtr:id><gtr:name>University of Helsinki</gtr:name><gtr:address><gtr:line1>Siltavuorenpenger 20 C</gtr:line1><gtr:line4>Helsinki</gtr:line4><gtr:line5>FI-00170</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/90586AE8-B1B4-4D85-B7CC-B9130F248E5C"><gtr:id>90586AE8-B1B4-4D85-B7CC-B9130F248E5C</gtr:id><gtr:name>University of Nebraska-Lincoln</gtr:name><gtr:address><gtr:line1>University of Nebraska-Lincoln</gtr:line1><gtr:line4>Lincoln</gtr:line4><gtr:line5>Nebraska</gtr:line5><gtr:postCode>68588-0340</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BF47D388-B1EE-4B33-810A-0EA666A7BC05"><gtr:id>BF47D388-B1EE-4B33-810A-0EA666A7BC05</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:otherNames>Leon</gtr:otherNames><gtr:surname>Collingridge</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F4AD6ADE-1675-400C-848E-8E1255496AF1"><gtr:id>F4AD6ADE-1675-400C-848E-8E1255496AF1</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:surname>Marrion</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C4B4329E-A731-4BC2-8CFC-7311340846E0"><gtr:id>C4B4329E-A731-4BC2-8CFC-7311340846E0</gtr:id><gtr:firstName>Elek</gtr:firstName><gtr:surname>Molnar</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8464CB93-4656-4173-A343-F91F40FA7F7D"><gtr:id>8464CB93-4656-4173-A343-F91F40FA7F7D</gtr:id><gtr:firstName>Zuner</gtr:firstName><gtr:otherNames>Assis</gtr:otherNames><gtr:surname>Bortolotto</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G9532377"><gtr:id>C03EB335-B61C-43AE-AFE6-CC3F1D1D90A6</gtr:id><gtr:title>Mechanisms of expression of NMDA receptor-dependent LTP and LTD in the hippocampus</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9532377</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-12-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1996-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>3710670</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of British Columbia (UBC)</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>YT Wang</gtr:description><gtr:id>F6557829-14B3-4ABC-AE04-24BDA936DBB5</gtr:id><gtr:impact>publications</gtr:impact><gtr:partnerContribution>Provision of experimental data</gtr:partnerContribution><gtr:piContribution>Provision of experimental data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Novartis</gtr:description><gtr:id>D4CD86F1-FDEA-4FF7-B5CE-B4E7B181B0FF</gtr:id><gtr:impact>publications</gtr:impact><gtr:partnerContribution>provision of NR selective antagonist</gtr:partnerContribution><gtr:piContribution>provision of antagonist</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Helsinki (Helsingin yliopisto)</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:description>Sari Lauri</gtr:description><gtr:id>19AA8A75-98F2-4819-8759-5F0A837227B2</gtr:id><gtr:impact>publications</gtr:impact><gtr:partnerContribution>experimental data</gtr:partnerContribution><gtr:piContribution>produced principal experimental data for publications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GSK</gtr:description><gtr:id>68900119-CD30-45C3-8A9B-39F22242428E</gtr:id><gtr:impact>Publications</gtr:impact><gtr:partnerContribution>provision of transgenic animals</gtr:partnerContribution><gtr:piContribution>Provision of transgenic animals</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eli Lilly &amp; Company Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Eli Lilly</gtr:description><gtr:id>2408A708-7963-44B2-88C1-40AD12A09525</gtr:id><gtr:impact>New antagonists developed, eg UBP296</gtr:impact><gtr:partnerContribution>screening of cloned receptors</gtr:partnerContribution><gtr:piContribution>Screening of cloned receptors for KAR antagonists</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nebraska?Lincoln</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Nebraska Medical Centre</gtr:department><gtr:description>DT Monaghan</gtr:description><gtr:id>641A8ED2-6DD8-4D1E-A51A-4EE5FD6ED7B5</gtr:id><gtr:impact>Publications in relevant journals</gtr:impact><gtr:partnerContribution>Initial pharmacological characterisation of allosteric modulators using Xenopus Oocyte preparations.</gtr:partnerContribution><gtr:piContribution>Initial synthesis of novel compounds that act as NMDA receptor allosteric modulators. Analysis of effects on plasticty in in vitro slice preparations.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Brain Awareness Week/Science Alive</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9E00DB1B-7FC4-4530-99CC-E6B7FCEE20EE</gtr:id><gtr:impact>Hands on activities in a local shopping centre where the general public could do activities and learn about the work we do.

Interest in our research</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>public talks - various</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>55A0B78D-6030-45C8-B134-3FC1B336CA5E</gtr:id><gtr:impact>Talks to public audiences on aspects of our work

interst in our work</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visits - various</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BA51EF65-9737-4D57-9DD7-2A28BBB6EE6F</gtr:id><gtr:impact>talks and activities about the brain and how memory works

Interst from school children</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1866640</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>38EB880A-0809-4213-973B-33294BB49FF5</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Software to deliver stimuli and to analyse electrophysiological recordings</gtr:description><gtr:id>0830753F-E234-4863-938F-FA0EEA75A60F</gtr:id><gtr:impact>Software is being used in laboratories across the world to further knowledge</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:protection>Copyrighted (e.g. software)</gtr:protection><gtr:title>Win LTP software</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Software for the delivery of stimuli and e=analysis of electrophysiologigal data</gtr:description><gtr:id>FE0AC18B-9BFF-4D74-BCC6-7AAAF7728A96</gtr:id><gtr:impact>adding to the research ability of labs across the world</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Win LTP - software</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>Software to perform electrophysiological experiments</gtr:description><gtr:id>30CB8399-5C2F-414A-A708-ECA94EA64E40</gtr:id><gtr:impact>This software is currently in use in a range of laboratories throughout the world</gtr:impact><gtr:title>WinLTP</gtr:title><gtr:type>Software</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E1AFADA1-94BD-4B47-96AD-82B7DA746707"><gtr:id>E1AFADA1-94BD-4B47-96AD-82B7DA746707</gtr:id><gtr:title>Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices expressing a C-terminal truncated GABA(B2) receptor subunit.</gtr:title><gtr:parentPublicationTitle>Epilepsy research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6782b8d792dd00f7fb03bfa38fc59c05"><gtr:id>6782b8d792dd00f7fb03bfa38fc59c05</gtr:id><gtr:otherNames>Thuault SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0920-1211</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B0C23F22-2A97-4298-94AD-71A01F9A71F0"><gtr:id>B0C23F22-2A97-4298-94AD-71A01F9A71F0</gtr:id><gtr:title>Bi-directional modulation of AMPA receptor unitary conductance by synaptic activity.</gtr:title><gtr:parentPublicationTitle>BMC neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3879dd20d277fe5cce4831e38872c424"><gtr:id>3879dd20d277fe5cce4831e38872c424</gtr:id><gtr:otherNames>L?thi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1471-2202</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AD88DB9F-4A57-4D3D-B45C-F20F3B17587A"><gtr:id>AD88DB9F-4A57-4D3D-B45C-F20F3B17587A</gtr:id><gtr:title>Tyrosine phosphatases regulate AMPA receptor trafficking during metabotropic glutamate receptor-mediated long-term depression.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b776dfe698d77f95889b417812608a15"><gtr:id>b776dfe698d77f95889b417812608a15</gtr:id><gtr:otherNames>Moult PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9FDDB198-9C69-4684-A29D-5DB1297B6D39"><gtr:id>9FDDB198-9C69-4684-A29D-5DB1297B6D39</gtr:id><gtr:title>Hippocalcin functions as a calcium sensor in hippocampal LTD.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c5e23f6c64bb0a5f38e7a7d992e41a3b"><gtr:id>c5e23f6c64bb0a5f38e7a7d992e41a3b</gtr:id><gtr:otherNames>Palmer CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A7EC6FFA-D2B3-4CE8-AA15-8B0B1907FB25"><gtr:id>A7EC6FFA-D2B3-4CE8-AA15-8B0B1907FB25</gtr:id><gtr:title>Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b3a6822d61ed9e993c609431e7d20d74"><gtr:id>b3a6822d61ed9e993c609431e7d20d74</gtr:id><gtr:otherNames>Dolman NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66F0BA1F-D230-45C2-91D3-4CB5CECDE19C"><gtr:id>66F0BA1F-D230-45C2-91D3-4CB5CECDE19C</gtr:id><gtr:title>Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f60051e9db58e4e8a59e6acb2f2659f"><gtr:id>6f60051e9db58e4e8a59e6acb2f2659f</gtr:id><gtr:otherNames>Massey PV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8444C6D3-228E-4AB7-B688-E21720EA237C"><gtr:id>8444C6D3-228E-4AB7-B688-E21720EA237C</gtr:id><gtr:title>LTP inhibits LTD in the hippocampus via regulation of GSK3beta.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25296974b6821f058afc51d5ccac2a48"><gtr:id>25296974b6821f058afc51d5ccac2a48</gtr:id><gtr:otherNames>Peineau S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/932348EB-E37A-4AE4-B763-47FE0C113686"><gtr:id>932348EB-E37A-4AE4-B763-47FE0C113686</gtr:id><gtr:title>Multiple, developmentally regulated expression mechanisms of long-term potentiation at CA1 synapses.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f9b61d75f7819a3780ee587e367b12a9"><gtr:id>f9b61d75f7819a3780ee587e367b12a9</gtr:id><gtr:otherNames>Palmer MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A18B8C2F-7435-445E-B271-B6AC76D5E843"><gtr:id>A18B8C2F-7435-445E-B271-B6AC76D5E843</gtr:id><gtr:title>Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f84c771e11ed7b214320b224cc8a61ad"><gtr:id>f84c771e11ed7b214320b224cc8a61ad</gtr:id><gtr:otherNames>More JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/23BFAF8E-3452-47B3-B225-CE7EF260F9A6"><gtr:id>23BFAF8E-3452-47B3-B225-CE7EF260F9A6</gtr:id><gtr:title>The GABA(B2) subunit is critical for the trafficking and function of native GABA(B) receptors.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6782b8d792dd00f7fb03bfa38fc59c05"><gtr:id>6782b8d792dd00f7fb03bfa38fc59c05</gtr:id><gtr:otherNames>Thuault SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5048A7EB-BD88-4E5D-A030-AED02E6F9E3F"><gtr:id>5048A7EB-BD88-4E5D-A030-AED02E6F9E3F</gtr:id><gtr:title>Synaptic transmission and synchronous activity is disrupted in hippocampal slices taken from aged TAS10 mice.</gtr:title><gtr:parentPublicationTitle>Hippocampus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6c1b65c02d2ead34c6c2f368700c538a"><gtr:id>6c1b65c02d2ead34c6c2f368700c538a</gtr:id><gtr:otherNames>Brown JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1050-9631</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F892F8EA-B3DF-4F93-9EA9-35DD8C26D266"><gtr:id>F892F8EA-B3DF-4F93-9EA9-35DD8C26D266</gtr:id><gtr:title>Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/364b15fc5ae96fbed70445d1d2fb7bf7"><gtr:id>364b15fc5ae96fbed70445d1d2fb7bf7</gtr:id><gtr:otherNames>Bartlett TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EECF52CB-030F-4BD4-980F-0B3B9D0CC83D"><gtr:id>EECF52CB-030F-4BD4-980F-0B3B9D0CC83D</gtr:id><gtr:title>Transient incorporation of native GluR2-lacking AMPA receptors during hippocampal long-term potentiation.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/03ce74148e29f411bd07e7c7c0fcda07"><gtr:id>03ce74148e29f411bd07e7c7c0fcda07</gtr:id><gtr:otherNames>Plant K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52257CE2-B33F-494F-BB4B-422BF52C9380"><gtr:id>52257CE2-B33F-494F-BB4B-422BF52C9380</gtr:id><gtr:title>Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ccfbe3010533a5f45f491ef9ace877dd"><gtr:id>ccfbe3010533a5f45f491ef9ace877dd</gtr:id><gtr:otherNames>Anderson WW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2C6AAD5F-84D9-4E0E-9FC4-5EFC478F8D5C"><gtr:id>2C6AAD5F-84D9-4E0E-9FC4-5EFC478F8D5C</gtr:id><gtr:title>Endogenous activation of kainate receptors regulates glutamate release and network activity in the developing hippocampus.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0a0cd335843ba72fbd6315752eb26583"><gtr:id>0a0cd335843ba72fbd6315752eb26583</gtr:id><gtr:otherNames>Lauri SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D9511482-0AD1-4FF3-91BE-290E073F3582"><gtr:id>D9511482-0AD1-4FF3-91BE-290E073F3582</gtr:id><gtr:title>Interactions between NMDA receptors and mGlu5 receptors expressed in HEK293 cells.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f362519c22936b1e2c6849fb6a4c8a3"><gtr:id>6f362519c22936b1e2c6849fb6a4c8a3</gtr:id><gtr:otherNames>Collett VJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F15621A3-B788-4F76-92B5-E38AC58F1731"><gtr:id>F15621A3-B788-4F76-92B5-E38AC58F1731</gtr:id><gtr:title>The regulation of hippocampal LTP by the molecular switch, a form of metaplasticity, requires mGlu5 receptors.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/10fb1f878664cbaa9ca7a7f7c164bd16"><gtr:id>10fb1f878664cbaa9ca7a7f7c164bd16</gtr:id><gtr:otherNames>Bortolotto ZA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9841F60C-FDB1-430B-B4C5-B137D53A23A4"><gtr:id>9841F60C-FDB1-430B-B4C5-B137D53A23A4</gtr:id><gtr:title>Characterisation of the effects of ATPA, a GLU(K5) kainate receptor agonist, on GABAergic synaptic transmission in the CA1 region of rat hippocampal slices.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f7cf6f2563680186dae404931d4c7d0f"><gtr:id>f7cf6f2563680186dae404931d4c7d0f</gtr:id><gtr:otherNames>Clarke VR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9532377</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>